SynthesisUnited European gastroenterology journal2025

Effectiveness and Treatment Persistence of Vedolizumab Compared to Anti-Tumour Necrosis Factor-α in Patients With Crohn's Disease: A Systematic Literature Review and Meta-Analysis.

Alessandro Armuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.